Medi-Cal youth gender-affirming services: October 13 reimbursement and continuity requirements
Oct 11, 2026 edition · GC-2026-0141 · Published 2026-10-11 · Version 3 · Final
APL 26-018 pairs youth reimbursement limits with a restricted hormone transition, preserved services, continuity coordination, and plan notices.
What happened
The September 30 letter limits reimbursement from October 13 for specified gender-affirming surgery, puberty blockers, and hormone therapy for Medi-Cal members under eighteen and CHIP members under nineteen. Hormones already being taken as of October 13 retain a transition through April 12, 2027; for affected MCP members, this applies only under the medical benefit. Surgery, blockers, and newly started hormones receive no such transition. Services for other medical indications and treatment of complications remain covered when medically necessary.
The letter preserves necessary ancillary services, earlier service dates, and unaffected ages. It directs coordination with HCAI state-only funding and says providers should not cancel or redirect care while reimbursement details develop. Plans must distribute approved handbook errata and issue individualized adverse-action notices when required, with ten-day advance notice where applicable, appeal rights, and continuation information. Policies, attestation, and copies are due within ninety calendar days of release, rather than requiring subsequent DHCS approval.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- California, Federal
- Affected functions
- Managed Care, Clinical Operations, Case Management, Revenue Cycle, Legal
- Responsible owner
- Managed Care
- Recorded date
- 2026-10-13
- Date type
- effective
Why it matters
The letter preserves medically necessary ancillary care, treatment for other indications and complications, pre-October 13 services, and unaffected ages. HCAI state-only funding supports continuity; providers should not cancel or redirect care while reimbursement details develop.
Recommended action
Validate exceptions and HCAI coordination immediately. Distribute the approved handbook errata and assess individualized adverse-action notices, including ten-day advance notice where applicable, appeal rights and continuation of benefits. Confirm the December 29 policy-submission target.
Implementation playbook
- Confirm affected services, exceptions, notices and continuity; internal target. Managed Care · Due 2026-10-12
- Apply service-date controls and coordinate HCAI funding. Revenue Cycle · Due 2026-10-13
- Submit policies and required confirmation within 90 days of release. Managed Care · Due 2026-12-29
Sources
- APL 26-018, Federal Reimbursement Limitation on Gender-Affirming Care Services for YouthOfficial · DHCS · 2026-09-30 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →